Michael W. Riggs, DVM, PhD, University of Arizona

Michael W. Riggs, DVM, PhD
Michael W. Riggs, DVM, PhD

His research interests center on the immunobiology and molecular pathogenesis of parasitic protozoal diseases of zoonotic importance. Current research is focused on development of recombinant and synthetic vaccines for cryptosporidiosis; immunotherapy and new drug discovery for cryptosporidiosis; definition of the molecular pathogenesis of host cell recognition, attachment, and invasion by Cryptosporidium; structural characterization of Cryptosporidium glycoprotein ligands; animal model development; and improved methods for diagnosis and detection.



  1. Schaefer, DA, Auerbach-Dixon, BA, and Riggs, MW. Characterization and formulation of multiple epitope-specific neutralizing monoclonal antibodies for passive immunization against cryptosporidiosis. 2000. Infect. Immun., 68(5), 2608-2616.
  2. Riggs, MW, Stone, AL, Yount, PA, Langer, RC, Arrowood, MJ, and Bentley, DL. Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites. 1997. J Immunol. 158, 1787-1795.